SCHEMBL30568545

SCHEMBL30568545

CN(CCCCCn1cnc2cccc(Br)c21)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRPS1 P60891 1/20 0.41
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 2/20 0.36
NPC1 O15118 1/20 0.35
NFKB1 P19838 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
GBA1 P04062 1/20 0.35
FPR3 P25089 1/20 0.34
FPR2 P25090 1/20 0.34
TRPV4 Q9HBA0 1/20 0.34
ALDH1A1 P00352 1/20 0.33
SSTR4 P31391 1/20 0.33
POLB P06746 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25345315 1.00 PRPS1 (0.41) PRPS1MAPTSMN1; SMN2MEN1HTT
SCHEMBL25344167 0.84 PRPS1 (0.42) PRPS1MAPTSMN1; SMN2MEN1HTT
SCHEMBL30568608 0.84 PRPS1 (0.42) PRPS1MAPTSMN1; SMN2MEN1HTT
SCHEMBL30568651 0.83 SSTR4 (0.45) PRPS1MAPTSMN1; SMN2MEN1HTT
SCHEMBL25343063 0.83 SSTR4 (0.45) PRPS1MAPTSMN1; SMN2MEN1HTT
SCHEMBL25346349 0.81 USP30 (0.35) GBA1TRPV4ALDH1A1PDK2
SCHEMBL30568483 0.81 USP30 (0.35) GBA1TRPV4ALDH1A1PDK2
SCHEMBL25344501 0.81 AAK1 (0.34) NPSR1GBA1FPR3FPR2TRPV4
SCHEMBL25343570 0.81 PRPS1 (0.39) PRPS1MAPTSMN1; SMN2MEN1HTT
SCHEMBL25346053 0.81 PRPS1 (0.46) PRPS1MAPTSMN1; SMN2MEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4472739-A1 IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2024-12-11 EP disclosed
WO-2023148129-A1 IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2023-08-10 WO disclosed